UBS Group’s Bluejay Diagnostics BJDX Stock Holding History
Bought
Maintained
Sold
Other funds holding BJDX
UBS Group's BJDX Position: Q3 2026 in Review
UBS Group opened a new position in Bluejay Diagnostics (BJDX) in Q3 2026: 149 shares worth $510. The stake represents ﹤0.01% of the portfolio and ranks #10596 among its holdings. This is a return to the name: UBS Group previously reported a position in BJDX as recently as Q1 2026.
UBS Group first reported a position in BJDX in Q3 2024 and has held it in 6 quarters since. The position peaked at $9.47K in Q4 2024. 13 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.
- UBS Group held 149 shares of Bluejay Diagnostics worth $510 as of Q3 2026.
- Bluejay Diagnostics was a new UBS Group position in Q3 2026.
- Bluejay Diagnostics made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10596 holding.
- UBS Group first reported a position in Bluejay Diagnostics in Q3 2024 and has held it in 6 quarters since.
- UBS Group's Bluejay Diagnostics position peaked at $9.47K in Q4 2024.
- 13 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.